Should Governments Impose Strict Price Caps on Life-Saving Prescription Drugs?
Analyze whether capping prescription drug prices prevents price-gouging on insulin and cancer drugs or destroys venture capital for pharmaceutical innovation.
Pick a Side
Choose a position to defend, or let fate assign your stance.
Arguments FOR
1. Stops Big Pharma from price-gouging patients with 1,000% markups on life-or-death medicines
American patients pay four times more for the exact same prescription drugs as patients in Canada and Europe; diabetics die from rationing $300 vials of insulin.
2. Much foundational drug discovery is funded directly by taxpayer dollars through the NIH
Taxpayers invest over $45 billion annually in basic scientific research at the NIH; pharmaceutical giants commercialize taxpayer discoveries and charge extortionate prices.
3. Pharmaceutical corporations spend vastly more on marketing and stock buybacks than on R&D
Corporate financial disclosures prove major drug companies spend nearly double on television commercials and shareholder dividends compared to lab research.
4. The 2022 Inflation Reduction Act proved capping insulin at $35 per month is life-saving and workable
Federal policy capping insulin for seniors showed that targeted price caps provide instant relief without bankrupting pharmaceutical giants.
Arguments AGAINST
1. Drastically reduces capital investment in high-risk research for rare and incurable diseases
Bringing a new drug from lab to market costs an average of $2.6 billion and carries a 90% failure rate; price caps destroy the financial incentive to take high-stakes risks.
2. Triggers catastrophic drug shortages, factory closures, and medical delays
Price controls historically distort supply chains; capping generic antibiotic and chemotherapy prices has caused chronic hospital shortages across America.
3. Other developed nations 'free-ride' on American patients who shoulder the global R&D burden
European price caps are only possible because American consumers pay high prices that subsidize the research for the entire world's medicine.
4. Promoting generic competition and patent reform is vastly superior to bureaucratic price fixing
Speeding up FDA generic approvals and stopping anti-competitive 'pay-for-delay' patent abuse lowers prices through free-market competition.
Counter Questions
Questions to challenge claims and probe deeper into trade-offs.
- Why did the inventors of insulin (Frederick Banting and Charles Best) sell their patent in 1923 for just $1 so the medicine would remain affordable for everyone?
- How did the Inflation Reduction Act of 2022 grant Medicare the legal authority to negotiate prices for the top 10 most expensive prescription drugs?
- If the US government caps drug prices at European levels, will global pharmaceutical companies reduce the total number of new drugs brought to clinical trials?
- Why does a bottle of Humira cost $7,000 in the United States but only $1,000 in Germany for the exact same medication?
- Could the government directly fund clinical drug trials through public prize funds rather than relying on 20-year monopoly patent markups?
Ready to debate this topic?
Prepare your arguments and test your speech against the clock.